| Literature DB >> 32226729 |
Joowon Lee1, Maura E Walker1, Karen A Matthews2, Lewis H Kuller3, Nalini Ranjit4, Kelley Pettee Gabriel5.
Abstract
In this study, we investigate the associations of objectively measured waking (sedentary, light physical activity [LPA] and moderate-to-vigorous physical activity [MVPA]) and sleep duration and quality characteristics with cardiometabolic risk among older women. Participants from the Healthy Women Study 2010-11 follow-up visit (n = 136, age = 73 ± 2 years, white = 91.9%) concurrently wore an ActiGraph GT1M accelerometer and Actiwatch-2 for seven days. A composite cardiometabolic risk score was calculated by transforming metabolic syndrome (MetS) components and summing z-scores. Multivariable regression models were fitted to relate waking and sleep estimates with the MetS z-score after adjustment for covariates. Compositional data analysis was used to predict the MetS z-score when fixed durations of time were reallocated from one characteristic to another. MVPA (per 10 min/day increase; β = -7.80, P < 0.01), LPA (per 30 min/day increase; β = -0.29, P = 0.04), and sleep efficiency (β = -0.10, P = 0.04) were inversely associated with MetS z-score, while sedentary time (per 30 min/day increase; β = 0.34, P = 0.01) was positively associated with MetS z-score. Reallocation of 5 min from MVPA to sleep, sedentary, or LPA resulted in the greatest predicted change in MetS z-score. On average, the reallocation of 5 min from MVPA to other characteristics predicted an 11% increase in triglycerides, 6% decrease in HDL-C, and 5% increase in waist circumference. Lastly, reallocating 30 min of sedentary time to LPA was associated with a modestly lower predicted MetS z-score. This study suggests that MVPA is the most important contributor of MetS and that maintaining MVPA and increasing LPA may be beneficial for reducing cardiometabolic risk among older women.Entities:
Keywords: Aerobic physical activity; Cardiometabolic health; Metabolic syndrome; Sleep quality
Year: 2020 PMID: 32226729 PMCID: PMC7093830 DOI: 10.1016/j.pmedr.2020.101071
Source DB: PubMed Journal: Prev Med Rep ISSN: 2211-3355
Characteristics of the analytic sample by metabolic syndrome status in the Healthy Women Study.
| Variable | Total (n = 136) | MetS (n = 42) | No MetS (n = 94) | P-value |
|---|---|---|---|---|
| Age, y | 73.3 ± 1.7 | 73.2 ± 1.7 | 73.4 ± 1.6 | 0.55 |
| White, n (%) | 124 (91.9) | 39 (95.1) | 85 (90.4) | 0.50 |
| High school or less | 30 (22.2) | 11 (26.8) | 19 (20.2) | |
| Some college | 30 (22.2) | 11 (26.8) | 19 (20.2) | |
| 4-y degree or higher | 75 (55.6) | 19 (46.3) | 56 (59.6) | 0.36 |
| BMI, kg/m2 | 27.6 ± 5.1 | 31.4 ± 5.2 | 25.7 ± 3.9 | <0.01* |
| Total cholesterol, mg/dL | 216.3 ± 45.2 | 212.9 ± 54.1 | 217.2 ± 41.3 | 0.61 |
| LDL-c, mg/dL | 124.6 ± 39.5 | 122.5 ± 46.2 | 124.8 ± 36.4 | 0.76 |
| Insulin, mU/dL | 13.3 ± 5.2 | 17.6 ± 5.3 | 11.3 ± 3.9 | <0.01* |
| Lipid-lowering medication | 67 (49.3) | 28 (41.8) | 39 (58.2) | <0.01* |
| Antihypertensive medication | 65 (47.8) | 36 (55.4) | 29 (44.6) | <0.01* |
| Antidiabetic medication | 8 (5.9) | 4 (2.9) | 4 (2.9) | 0.25 |
| WC (cm) | 90.3 ± 13.1 | 101.9 ± 11.4 | 85.1 ± 10.3 | <0.01* |
| HDL-c (mg/dL) | 68.0 ± 14.8 | 58.8 ± 13.8 | 72.1 ± 13.3 | <0.01* |
| Triglycerides (mg/dL) | 118.6 ± 51.0 | 158.4 ± 52.6 | 100.7 ± 38.9 | <0.01* |
| Glucose (mg/dL) | 103.5 ± 14.5 | 113.3 ± 17.1 | 99.1 ± 10.6 | <0.01* |
| SBP (mm Hg) | 122.9 ± 20.6 | 130.0 ± 20.1 | 119.7 ± 20.1 | <0.01* |
| DBP (mm Hg) | 65.4 ± 11.0 | 66.1 ± 11.4 | 65.0 ± 10.8 | 0.58 |
| MetS Z-score (sum of Z-scores) | −0.01 ± 3.2 | 3.3 ± 2.6 | −1.5 ± 2.3 | <0.01* |
| Wear time, min/day | 1044.2 ± 114.2 | 1060.1 ± 131.5 | 1037.1 ± 105.6 | 0.28 |
| Sedentary, min/day | 746.3 ± 108.2 | 773.7 ± 121.8 | 734.1 ± 99.8 | 0.05* |
| LPA, min/day | 284.9 ± 67.2 | 232.0 ± 49.9 | 287.4 ± 67.5 | 0.52 |
| MVPA, min/day | 12.9 ± 16.5 | 7.0 ± 9.5 | 15.6 ± 18.2 | <0.01* |
| Total sleep time (min) | 401.1 ± 53.9 | 396.3 ± 51.7 | 403.3 ± 55.0 | 0.49 |
| Efficiency (%) | 84.8 ± 6.1 | 83.0 ± 6.0 | 85.6 ± 6.0 | 0.02* |
| WASO (min) | 46.2 ± 23.6 | 52.5 ± 23.2 | 43.4 ± 23.3 | 0.04* |
| Onset latency (min) | 12.6 ± 9.8 | 13.8 ± 9.6 | 12.1 ± 9.9 | 0.36 |
| Fragmentation Index | 29.9 ± 11.5 | 32.6 ± 11.7 | 28.6 ± 11.3 | 0.06 |
Abbreviations: MetS, metabolic syndrome; CVD, cardiovascular disease; BMI, body mass index; LDL-c, low-density lipoprotein cholesterol; WC, waist circumference; HDL-c, high-density lipoprotein cholesterol; SBP, systolic blood pressure; DBP, diastolic blood pressure; LPA, light intensity physical activity; MVPA, moderate to vigorous physical Activity; WASO, wake after sleep onset.
Note: Values are mean ± standard deviation (SD) unless otherwise indicated; Freedson’s cut point was used to define the accelerometer-based physical activity estimates; We used a t-test to compare the means of continuous variables between groups and the chi-square test or Fisher’s exact test for comparisons of categorical variables between groups; *P < 0.05.
Association of waking and sleep characteristics with metabolic syndrome z-score.
| β (std. β) | 95% CI | P-value | |
|---|---|---|---|
| Log transformed MVPA (per 10 min/day) | −7.80 (−0.33) | −11.87, −3.75 | <0.01* |
| LPA (per 30 min/day) | −0.29 (−0.20) | −0.56, −0.02 | 0.04* |
| Sedentary Time (per 30 min/day) | 0.34 (0.39) | 0.09, 0.59 | 0.01* |
| Total sleep time (min) | 0.01 (0.11) | 0.00, 0.02 | 0.26 |
| Efficiency (%) | −0.10 (−0.19) | −0.20, −0.01 | 0.04* |
| SOL (min) | 0.05 (0.16) | −0.01, 0.11 | 0.08 |
| WASO (min) | 0.02 (0.18) | 0.00, 0.05 | 0.18 |
| Fragmentation index | 0.05 (0.17) | 0.00, 0.10 | 0.06 |
Abbreviations: std., standardized; CI, confidence interval; PA, physical activity; MVPA, moderate-to-vigorous physical activity; LPA, light intensity physical activity; SOL, sleep onset latency; WASO, Wake After Sleep Onset.
Note: Age, race, education, accelerometer wear time, use of antihypertensive and lipid-lowering medications were adjusted in the model; *P < 0.05.
Geometric means of activity behaviors by metabolic syndrome status.
| All (n = 136) | MetS (n = 55) | No MetS (n = 81) | |
|---|---|---|---|
| Sleep (min/day) | 402.62 | 396.30 | 407.23 |
| Sedentary (min/day) | 748.66 | 768.27 | 735.98 |
| LPA (min/day) | 282.24 | 271.79 | 287.28 |
| MVPA (min/day) | 6.48 | 3.63 | 9.50 |
Abbreviations: MetS, metabolic syndrome; min, minutes; LPA, light intensity physical activity; MVPA, moderate to vigorous physical activity.
Note: Compositional mean was adjusted to sum to 1440 min/day.
Compositional variation matrix of time spent in individual activity behaviors.
| Sedentary | LPA | MVPA | |
|---|---|---|---|
| Sleep | 0.05 | 0.09 | 1.86 |
| Sedentary | 0.00 | 0.09 | 1.93 |
| LPA | – | 0.00 | 1.69 |
Abbreviations: LPA, light physical activity; MVPA, moderate to vigorous physical activity.
Note: Values closer to zero indicated that the times spent in the two behaviors included in the ratio were highly co-dependent.
Predicted differences in metabolic syndrome z-score and individual metabolic syndrome components.
| MetS z-score | Sleep | Sedentary | LPA | MVPA |
|---|---|---|---|---|
| Sleep | – | 0.05 | −0.05 | −0.42 |
| Sedentary time | −0.05 | – | −0.10 | −0.43 |
| LPA | 0.05 | 0.11 | – | −0.41 |
| MVPA | 1.07 | 1.07 | 1.06 | – |
| Sleep | – | 0.77 | 0.99 | −1.78 |
| Sedentary time | −0.74 | – | 0.20 | −1.90 |
| LPA | −0.99 | −0.26 | – | −1.94 |
| MVPA | 4.65 | 4.78 | 4.81 | – |
| Sleep | – | 0.36 | 0.33 | 1.78 |
| Sedentary time | −0.34 | – | −0.03 | 1.71 |
| LPA | −0.31 | 0.03 | – | 1.72 |
| MVPA | −4.43 | −4.37 | −4.37 | – |
| Sleep | – | −0.20 | −0.39 | −5.08 |
| Sedentary time | 0.37 | – | −0.36 | −5.01 |
| LPA | 0.76 | 0.38 | – | −4.95 |
| MVPA | 12.78 | 12.71 | 12.65 | – |
| Sleep | – | −0.07 | −0.30 | −0.74 |
| Sedentary time | 0.06 | – | −0.20 | −0.73 |
| LPA | 0.39 | 0.32 | – | −0.67 |
| MVPA | 1.84 | 1.83 | 1.78 | – |
| Sleep | – | 0.32 | −1.42 | −0.59 |
| Sedentary time | −0.34 | – | −1.76 | −0.73 |
| LPA | 1.55 | 1.88 | – | −0.67 |
| MVPA | 1.46 | 1.51 | 1.21 | – |
| Sleep | – | 0.52 | −0.27 | 0.30 |
| Sedentary time | −0.52 | – | −0.81 | 0.21 |
| LPA | 0.35 | 0.85 | – | 0.35 |
| MVPA | −0.71 | −0.62 | −0.76 | – |
Abbreviations: MetS, metabolic syndrome; LPA, light intensity physical activity; MVPA, moderate to vigorous physical activity; WC, waist circumference; HDL-C, high-density lipoprotein cholesterol; SBP, systolic blood pressure; DBP, diastolic blood pressure.
Note: Reallocation of time from the behavior in rows to behaviors in columns. Reallocation between MVPA and other behaviors (sleep, sedentary, and LPA) is 5 min. The reallocation among sleep, sedentary, and LPA is 30 min. Models adjusted for age, race, education, accelerometer wear time, use of antihypertensive and lipid-lowering medications were adjusted in the model.
Fig. 1Predicted difference in metabolic syndrome z-score following 5 min of time reallocation to or from MVPA. Abbreviations: MVPA, moderate to vigorous physical activity, PA, physical activity. Note: Models are adjusted for age, race, education, use of antihypertensive and lipid-lowering medications were adjusted.